PULMOFIB 267MG TABLET 10'S
PULMOFIB 267MG TABLET 10'S

PULMOFIB 267MG TABLET 10'S

By MSN LABORATORIES PRIVATE LIMITED

medicine_prescription
This medicine requires Prescription
MRP 252.54
214.6615% OFF
2 Alternative Available arrow

Product Summary

Offer Price214.66
Your Savings ₹ 37.88 (15% on MRP)
Medicines with same composition as PULMOFIB 267MG TABLET 10'S

About PULMOFIB 267MG TABLET 10'S

  • PULMOFIB 267MG TABLET 10'S is a medication used for the treatment of idiopathic pulmonary fibrosis (IPF), a chronic and progressive lung disease characterized by the formation of scar tissue in the lungs. PULMOFIB 267MG TABLET 10'S works by reducing fibrosis and inflammation in the lungs, which helps slow down the progression of IPF and improves lung function. It is believed to inhibit the production of certain growth factors and cytokines involved in the fibrotic process. PULMOFIB 267MG TABLET 10'S is available in oral form and is usually taken three times a day with food. It is an important therapeutic option for individuals with IPF, as it has been shown to slow down disease progression and improve lung function in clinical trials.

Uses of PULMOFIB 267MG TABLET 10'S

  • Helps in treating idiopathic pulmonary fibrosis (IPF).
  • Is used in slowing down the progression of IPF.
  • Aids in improving lung function.
  • Is used in reducing fibrosis and inflammation in the lungs.
  • Helps in managing symptoms associated with IPF.
  • Is used in improving exercise tolerance in IPF patients.
  • Aids in prolonging survival in individuals with IPF.

How PULMOFIB 267MG TABLET 10'S Works

  • PULMOFIB 267MG TABLET 10'S works by reducing fibrosis and inflammation in the lungs, slowing down the progression of idiopathic pulmonary fibrosis (IPF).
  • PULMOFIB 267MG TABLET 10'S exerts its therapeutic effects in idiopathic pulmonary fibrosis (IPF) through multiple mechanisms. It is believed to inhibit the synthesis and release of various pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1β), and transforming growth factor-beta (TGF-beta). By reducing the levels of these cytokines, PULMOFIB 267MG TABLET 10'S helps decrease inflammation and fibrosis in the lungs. It also inhibits the production of fibroblast growth factors (FGFs) and platelet-derived growth factors (PDGFs), which are involved in the excessive formation of scar tissue. Moreover, PULMOFIB 267MG TABLET 10'S has antioxidant properties that protect lung cells from oxidative stress, further contributing to its anti-fibrotic effects. These combined actions help slow down the progression of IPF, improve lung function, and alleviate symptoms in affected individuals.

Dosage of PULMOFIB 267MG TABLET 10'S Works

  • Dosage for children: The safety and effectiveness of PULMOFIB 267MG TABLET 10'S in children have not been established. It is typically prescribed for adult patients with idiopathic pulmonary fibrosis (IPF).
  • Dosage for adults: The usual dosage of PULMOFIB 267MG TABLET 10'S for adults is 267 mg taken orally three times a day with food, for a total daily dose of 801 mg. However, the specific dosage and treatment duration may vary based on individual factors and the prescribing healthcare professional's recommendations.

Side Effects Of PULMOFIB 267MG TABLET 10'S

Common Side Effects of PULMOFIB 267MG TABLET 10'S
  • Nausea
  • Diarrhea
  • Loss of appetite
  • Fatigue
  • Skin rash

How to Store PULMOFIB 267MG TABLET 10'S

  • Store PULMOFIB 267MG TABLET 10'S at room temperature (around 25°C or 77°F).
  • Keep it in its original container, tightly closed.
  • Protect from moisture and direct sunlight.
  • Keep it out of reach of children.

Frequently asked questions about PULMOFIB 267MG TABLET 10'S

PULMOFIB 267MG TABLET 10'S is used for the treatment of idiopathic pulmonary fibrosis (IPF).

The common side effects of PULMOFIB 267MG TABLET 10'S include nausea, diarrhea, loss of appetite, fatigue, and skin rash.

PULMOFIB 267MG TABLET 10'S should be stored at room temperature, protected from moisture and direct sunlight.

PULMOFIB 267MG TABLET 10'S works by reducing fibrosis and inflammation in the lungs, slowing down the progression of idiopathic pulmonary fibrosis (IPF).

PULMOFIB 267MG TABLET 10'S is not typically used in children, as its safety and effectiveness in pediatric patients have not been established.

PULMOFIB 267MG TABLET 10'S is generally safe to use when taken as directed by a healthcare professional.

The recommended dosage of PULMOFIB 267MG TABLET 10'S for adults is 267 mg taken orally three times a day with food.

It is important to consult a healthcare professional before taking PULMOFIB 267MG TABLET 10'S with other medications to check for potential drug interactions.

References related to PULMOFIB 267MG TABLET 10'S

  1. https://www.facebook.com/Drugscom. Pirfenidone Uses, Side Effects & Warnings. Drugs.com. Published 2022. Accessed June 19, 2023. https://www.drugs.com/mtm/pirfenidone.html ‌ image
Customer Reviews

Naresh Shah

Jenerik medicines is best than regular branded medicines. Extra ordinary benefit against branded med

Show More

Reviewed on 06 Jan 2024

Naresh Shah

Reviewed on 06 Jan 2024

Jenerik medicines is best than regular branded medicines. Extra ordinary benefit against branded med Show More

khozema kaukawala

Well satisfying products. Generic medicines are way cheaper and of very good quality. Staff is wel

Show More

Reviewed on 08 Sep 2023

khozema kaukawala

Reviewed on 08 Sep 2023

Well satisfying products. Generic medicines are way cheaper and of very good quality. Staff is wel Show More

Jigar Jani

Reliable and accessible pharmacy. Courteous and helpful people.

Reviewed on 29 Aug 2023

Jigar Jani

Reviewed on 29 Aug 2023

Reliable and accessible pharmacy. Courteous and helpful people.

Milind Patel

Very cheap, helpful, friendly service

Reviewed on 10 Feb 2023

Milind Patel

Reviewed on 10 Feb 2023

Very cheap, helpful, friendly service

PRASHANT KATARIYA

Great experience👍🏻

Reviewed on 29 Jan 2024

PRASHANT KATARIYA

Reviewed on 29 Jan 2024

Great experience👍🏻

See More Reviews